European Biotech Forum 2026
2026-06-11 09:00 - 13:30 (Europe/Brussels)
EuropaBio is a proud sponsor of the European Biotech Forum 2026.

Biotechnology is becoming a decisive capability for Europe’s competitiveness, industrial resilience and strategic autonomy. But Europe enters the next institutional cycle with a fragmented policy landscape, uneven regulatory capacity, and persistent scale-up barriers. The Commission’s Biotech Communication I and Biotech Communication II set out an initial toolbox, but fall short of an end-to-end industrial framework comparable to the US. The gap between ambition and execution remains significant. To what extent do these communications address the core challenges of Europe’s biotech sector? Where are the structural gaps that still block growth and industrial deployment?

More Info & Registration Here

Preparing for scale: industrial readiness and infrastructure access
2026-06-25 13:00 - 14:00
APROVALS Webinar Series – Public Session

This is the first session of the APROVALS public webinar series, a programme of collective learning events open to companies participating in the project and to the broader industrial ecosystem.

APROVALS webinars are designed to go beyond individual sandbox sessions: they create a shared space where companies can compare experiences, discuss cross-cutting challenges, and engage with external experts on the topics that matter most to scaling innovative technologies.

Session #1 – Preparing for scale: industrial readiness and infrastructure access

One of the most strategic — and most frequently asked — questions among APROVALS participants: how do you know when you are ready to move from pilot to industrial scale?

This session will explore:

The key signals and criteria that indicate readiness for industrialisation

Common bottlenecks companies face when scaling from lab or pilot to full production

Frameworks and options available to navigate this transition in a structured way

We’ll discuss with:

Rob Kooijmans (Food Safety)

Reza Ranjbar (AartinBio)

More Info Here

EuropaBio Biomanufacturing Policy Summit 2026
2026-07-01 09:30 - 13:30
From legislation to impact for Europe

Biomanufacturing lies at the heart of Europe’s future societal and entrepreneurial strength and is changing the business landscape for both emerging innovators and established industry champions.

EuropaBio’s 4th Biomanufacturing Policy Summit will focus on how legislation delivers impact within a proactive Biomanufacturing strategy, and how we establish EU targets for outcomes. It will also showcase the 2026 update of the EuropaBio WIfoR study ‘Measuring the Economic Footprint of the Biotechnology Industry in the European Union’ prior to full report launch in September.

The prize is globally competitive multi-sector biomanufacturing, keeping pace with industrial transition in major global regions and securing Europe’s supply chains, healthcare future, decarbonisation and economic resilience.

This meeting will bring together EuropaBio Members, representatives of key sectors, plus national and EU stakeholders across institutions.

This event will be accessible by invitation only, for more information contact us at: communications@europabio.org and c.skentelbery@europabio.org

EFIB Den Haag Statement - A modernised European Union for Industrial Biotechnology
2026-07-13 10:00 - 11:00
The EFIB 2026 Den Haag Statement was published following the successful workshops and sessions that EuropaBio organised during the Bio Innovations Europe conference on the 10th & 11th of June. It looks ahead to the decisions that the EU must now take through the policies and initiatives currently in process. A key opportunity exists for societal and industrial transformation within the sustainability and safety ambitions that make Europe a global figurehead.

The agenda of the webinar is as follows:

Presentation of the EFIB statement by our Director General, Claire Skentelbery.

Discussion with Lauren Kjeldsen, Management Board member of Evonik

This will be followed by a short Q&A session.

Register Here

Prague.bio Conference 2026
2026-09-23 08:00 - 20:00
Join our Director General Dr Claire Skentelbery at the 4th edition of Prague.bio Conference!

If you want to meet and network with biotech leaders shaping the CEE region, Prague.bio Conference 2026 is the place to be

Expect 400+ participants, partnering via the conference app, inspiring keynotes, panel discussions, hands-on workshops, and pitch & poster sessions.

More Info Here & Tickets

World Orphan Drug Congress 2026
2026-10-26 08:00 - 2026-10-28 20:00
The World Orphan Drug Congress Europe is the largest and most established event globally for orphan drugs and rare diseases.

Join over 1,800 senior industry leaders, gain insights from 250+ expert speakers, and connect with over 100 exhibitors driving progress across the entire orphan drug lifecycle. From regulatory strategy and market access to patient engagement and the latest breakthroughs in gene and cell therapies, the congress delivers practical insights you can apply immediately.

Network with the most senior individuals across the industry, including leaders in R&D, gene therapy, rare diseases, precision/personalised medicine, genetic disorders, patient advocacy and engagement, associations in ATMPs, investors, regulatory affairs professions, governmental bodies, and more…

More Info Here
